CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Momenta Pharmaceuticals, Inc. v. Teva Pharmaceuticals Industries Ltd.

1:10-cv-12079

Overview

Case Number 1:10-cv-12079
Filing Date 2010-12-02
Status Terminated
Termination Date 2016-03-03
Court District Court, D. Massachusetts (mad)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Mediator

Judith G. Dein NPE (Individual / Inventor)

Represented By

0 Attorneys Listed
No attorneys available

Defendant

Teva Pharmaceutical Industries, Ltd. Operating Company

Represented By

5 Attorneys Listed

Robert Frederickson , III

Goodwin Procter LLP

Tel: +1 (617) 570-1000
Fax: +1 (617) 523-1231

Exchange Place, 53 State Street

James Rehnquist

Goodwin Procter, LLP

Tel: +1 (617) 570-1820
Fax: +1 (617) 523-1231

Exchange Place, 53 State Street

David M. Hashmall

Goodwin Procter LLP

Tel: +1 (212) 813-8800
Fax: +1 (212) 355-3333

The New York Times Buildings, 620 Eighth Avenue

Adam R. Wichman

Goodwin Procter, LLP

Tel: +1 (617) 570-3973

One Exchange Place, 53 State Street

Elaine Herrmann Blais

Goodwin Procter LLP

Tel: +1 (617) 570-1205
Fax: +1 (617) 523-1231

Exchange Place, 53 State Street

Teva Pharmaceuticals USA, Inc. Operating Company

Represented By

6 Attorneys Listed

Robert Frederickson , III

Goodwin Procter LLP

Tel: +1 (617) 570-1000
Fax: +1 (617) 523-1231

Exchange Place, 53 State Street

James Rehnquist

Goodwin Procter, LLP

Tel: +1 (617) 570-1820
Fax: +1 (617) 523-1231

Exchange Place, 53 State Street

Daniel B. Reagan

Goodwin Procter, LLP

Tel: +1 (617) 570-1000

One Exchange Place, 53 State Street

David M. Hashmall

Goodwin Procter LLP

Tel: +1 (212) 813-8800
Fax: +1 (212) 355-3333

The New York Times Buildings, 620 Eighth Avenue

Adam R. Wichman

Goodwin Procter, LLP

Tel: +1 (617) 570-3973

One Exchange Place, 53 State Street

Elaine Herrmann Blais

Goodwin Procter LLP

Tel: +1 (617) 570-1205
Fax: +1 (617) 523-1231

Exchange Place, 53 State Street

Teva Pharmaceuticals USA Inc Operating Company

Represented By

8 Attorneys Listed

Joshua A. Whitehill

Goodwin Procter LLP

Tel: +1 (212) 459-7289
Fax: +1 (212) 355-3333

The New York Times Building, 620 Eighth Avenue

G. Mark Edgarton

Choate, Hall & Stewart LLP

Tel: +1 (617) 248-5101
Fax: +1 (617) 248-4000

Two International Place, 100-150 Oliver Street

Robert Frederickson , III

Goodwin Procter LLP

Tel: +1 (617) 570-1000
Fax: +1 (617) 523-1231

Exchange Place, 53 State Street

James Rehnquist

Goodwin Procter, LLP

Tel: +1 (617) 570-1820
Fax: +1 (617) 523-1231

Exchange Place, 53 State Street

Daniel B. Reagan

Goodwin Procter, LLP

Tel: +1 (617) 570-1000

One Exchange Place, 53 State Street

David M. Hashmall

Goodwin Procter LLP

Tel: +1 (212) 813-8800
Fax: +1 (212) 355-3333

The New York Times Buildings, 620 Eighth Avenue

Adam R. Wichman

Goodwin Procter, LLP

Tel: +1 (617) 570-3973

One Exchange Place, 53 State Street

Elaine Herrmann Blais

Goodwin Procter LLP

Tel: +1 (617) 570-1205
Fax: +1 (617) 523-1231

Exchange Place, 53 State Street

Plaintiff

Amphastar Pharmaceuticals, Inc. Operating Company

Represented By

1 Attorneys Listed

Taylor C. Foss

K & L Gates LLP

Tel: +1 (949) 623-3522

1 Park Plaza, 12th Floor

Momenta Pharmaceuticals, Inc. Operating Company

Represented By

9 Attorneys Listed

Daniel C. Winston

Choate, Hall & Stewart

Tel: +1 (617) 248-5000
Fax: +1 (617) 248-4000

Choate, Hall & Stewart, Two International Place

G. Mark Edgarton

Choate, Hall & Stewart LLP

Tel: +1 (617) 248-5101
Fax: +1 (617) 248-4000

Two International Place, 100-150 Oliver Street

Robert S. Frank , Jr.

Choate, Hall & Stewart

Tel: +1 (617) 248-5207
Fax: +1 (617) 248-4000

Choate, Hall & Stewart, Two International Place

Eric J. Marandett

Choate, Hall & Stewart

Tel: +1 (617) 248-5000
Fax: +1 (617) 248-4000

Choate, Hall & Stewart, Two International Place

Sophie F. Wang

Choate, Hall & Stewart

Tel: +1 (617) 248-4052

Choate, Hall & Stewart, Two International Place

Michael E. Murawski

Choate, Hall & Stewart LLP

Tel: +1 (617) 248-4996
Fax: +1 (617) 502-4996

Two International Place, 100-150 Oliver Street

Kara B. Coen

Gibson, Dunn & Crutcher

Tel: +1 (202) 955-8500
Fax: +1 (202) 467-0539

Gibson, Dunn & Crutcher, 1050 Connecticut Avenue, N.W.

Jessica Gan Lee

Choate, Hall & Stewart LLP

Tel: +1 (617) 248-5000
Fax: +1 (617) 248-4000

Two International Place, 100-150 Oliver Street

Anna Rachel Dray-Siegel

Attorney General's Office

Tel: +1 (617) 963-2022

Administrative Law Division, One Ashburton Place

Counter Claimant

Sandoz Inc. Operating Company

Represented By

6 Attorneys Listed

Sarah Chapin Columbia

McDermott, Will & Emery LLP

Tel: +1 (617) 535-4074
Fax: +1 (617) 535-3800

28 State Street, Boston, MA 02109

G. Mark Edgarton

Choate, Hall & Stewart LLP

Tel: +1 (617) 248-5101
Fax: +1 (617) 248-4000

Two International Place, 100-150 Oliver Street

Melissa Nott Davis

McDermott, Will & Emery LLP

Tel: +1 (617) 535-4189
Fax: +1 (617) 535-3800

28 State Street, Boston, MA 02109

Thomas P. Steindler

McDermott Will & Emery LLP

Tel: +1 (202) 756-8254

500 North Capitol Street, N.W., Washington, DC 20001

Michael E. Murawski

Choate, Hall & Stewart LLP

Tel: +1 (617) 248-4996
Fax: +1 (617) 502-4996

Two International Place, 100-150 Oliver Street

Jessica Gan Lee

Choate, Hall & Stewart LLP

Tel: +1 (617) 248-5000
Fax: +1 (617) 248-4000

Two International Place, 100-150 Oliver Street

Court & Judges

Court

District Court, D. Massachusetts (mad)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 6 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 1 proceeding
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (6): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (1 found):
U.S. Courts: 1
U.S. District Court 2011-09-21
1:11-cv-11681

Momenta Pharmaceuticals, Inc. v. Amphastar Pharmaceuticals, Inc.

Asserted Patent
Status: MAD
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7790466
Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping
Filed: 2008-01-25
Issued: 2010-09-07
Active (1.2 yrs remaining)
Expires: 2028-01-25
US7575886
Analysis of sulfated polysaccharides
Filed: 2003-03-11
Issued: 2009-08-18
Expiring Soon (97 days) +1447d PTA
Expires: 2027-02-25

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

115

Dispositive

30

Granted

0

Denied

3

Pending / Review

110

Motions by Category

Procedural / Extension Motion 44 Claim Construction / Markman Filing 33 Motion to Stay 2 Motion for Summary Judgment (Rule 56) 13 Motion for Summary Judgment (Infringement) 17 Motion to Strike / Sanctions 6

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Infringement) Pending / Under Review
Judge Nathaniel M. Gorton: ORDER entered. MEMORANDUM AND ORDER, granting 144 MOTION to Strike Plaintiffs' Third Amended Infringement Contentions file...
Entry #205 • 2013-07-19 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
ELECTRONIC Clerk's Notes for proceedings held before Judge Nathaniel M. Gorton: Motion Hearing held on 7/1/2013 re 144 MOTION to Strike Plaintiffs' Third Amende...
Entry #202 • 2013-07-01 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
ELECTRONIC NOTICE Resetting Hearing on Motion 161 MOTION to Amend, 135 MOTION for Summary Judgment (Teva Pharmaceuticals USA, Inc.'s Motion for Judgment on the ...
Entry #201 • 2013-06-25 Document →
Motion for Summary Judgment (Rule 56) Denied
Judge Nathaniel M. Gorton: ENDORSED ORDER entered denying 181 Emergency MOTION to Intervene for the Limited Purpose of Receiving a Redacted Version of Plaintiff...
Entry #197 • 2013-05-17 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
REPLY to Response to 181 Emergency MOTION to Intervene for the Limited Purpose of Receiving a Redacted Version of Plaintiffs' Opposition Papers to Teva's Motion...
Entry #196 • 2013-05-14 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
MOTION for Leave to File Reply in Support of Motion to Intervene for the Limited Purpose of Receiving a Redacted Version of Plaintiffs' Opposition Papers to Tev...
Entry #193 • 2013-05-13 Document →

Docket Entries

(277 total)
Pleading / Complaint

COMPLAINT against All Defendants Filing fee: $ 350, receipt number 0101-3173882 (Fee Status: Filing Fee paid), filed by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Attachments: # 1 Exhibit A1 '886 Patent, # 2 Exhibit A2 '886 Patent, # 3 Exhibit A3 '886 Patent, # 4 Exhibit A4 '886 Patent, # 5 Exhibit A5 '886 Patent, # 6 Exhibit B1 '466 Patent, # 7 Exhibit B2 '466 Patent, # 8 Exhibit B3 '466 Patent, # 9 Exhibit C Teva's Q4 Earnings Conference Transcript, # 10 Exhibit D Teva's Q1 2010 Earnings Call, # 11 Exhibit E Teva's Press Release, # 12 Exhibit F Teva's Q2 2010 Earnings Conference Transcript, # 13 Exhibit G Teva Article, # 14 Exhibit H Teva's Q3 2010 Earnings Conference Transcript, # 15 Civil Cover Sheet, # 16 Category Form)(Murawski, Michael) (Entered: 12/02/2010)

Entry #1 • 2010-12-02
1
Pleading / Complaint

COMPLAINT against All Defendants Filing fee: $ 350, receipt number 0101-3173882 (Fee Status: Filing Fee paid), filed by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Attachments: # 1 Exhibit A1 '886 Patent, # 2 Exhibit A2 '886 Patent, # 3 Exhibit A3 '886 Patent, # 4 Exhibit A4 '886 Patent, # 5 Exhibit A5 '886 Patent, # 6 Exhibit B1 '466 Patent, # 7 Exhibit B2 '466 Patent, # 8 Exhibit B3 '466 Patent, # 9 Exhibit C Teva's Q4 Earnings Conference Transcript, # 10 Exhibit D Teva's Q1 2010 Earnings Call, # 11 Exhibit E Teva's Press Release, # 12 Exhibit F Teva's Q2 2010 Earnings Conference Transcript, # 13 Exhibit G Teva Article, # 14 Exhibit H Teva's Q3 2010 Earnings Conference Transcript, # 15 Civil Cover Sheet, # 16 Category Form)(Murawski, Michael) (Entered: 12/02/2010)

Entry #1 • 2010-12-02
2
Pleading / Complaint

COMPLAINT against All Defendants Filing fee: $ 350, receipt number 0101-3173882 (Fee Status: Filing Fee paid), filed by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Attachments: # 1 Exhibit A1 '886 Patent, # 2 Exhibit A2 '886 Patent, # 3 Exhibit A3 '886 Patent, # 4 Exhibit A4 '886 Patent, # 5 Exhibit A5 '886 Patent, # 6 Exhibit B1 '466 Patent, # 7 Exhibit B2 '466 Patent, # 8 Exhibit B3 '466 Patent, # 9 Exhibit C Teva's Q4 Earnings Conference Transcript, # 10 Exhibit D Teva's Q1 2010 Earnings Call, # 11 Exhibit E Teva's Press Release, # 12 Exhibit F Teva's Q2 2010 Earnings Conference Transcript, # 13 Exhibit G Teva Article, # 14 Exhibit H Teva's Q3 2010 Earnings Conference Transcript, # 15 Civil Cover Sheet, # 16 Category Form)(Murawski, Michael) (Entered: 12/02/2010)

Entry #1 • 2010-12-02
2
Pleading / Complaint

COMPLAINT against All Defendants Filing fee: $ 350, receipt number 0101-3173882 (Fee Status: Filing Fee paid), filed by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Attachments: # 1 Exhibit A1 '886 Patent, # 2 Exhibit A2 '886 Patent, # 3 Exhibit A3 '886 Patent, # 4 Exhibit A4 '886 Patent, # 5 Exhibit A5 '886 Patent, # 6 Exhibit B1 '466 Patent, # 7 Exhibit B2 '466 Patent, # 8 Exhibit B3 '466 Patent, # 9 Exhibit C Teva's Q4 Earnings Conference Transcript, # 10 Exhibit D Teva's Q1 2010 Earnings Call, # 11 Exhibit E Teva's Press Release, # 12 Exhibit F Teva's Q2 2010 Earnings Conference Transcript, # 13 Exhibit G Teva Article, # 14 Exhibit H Teva's Q3 2010 Earnings Conference Transcript, # 15 Civil Cover Sheet, # 16 Category Form)(Murawski, Michael) (Entered: 12/02/2010)

Entry #1 • 2010-12-02
2
Pleading / Complaint

COMPLAINT against All Defendants Filing fee: $ 350, receipt number 0101-3173882 (Fee Status: Filing Fee paid), filed by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Attachments: # 1 Exhibit A1 '886 Patent, # 2 Exhibit A2 '886 Patent, # 3 Exhibit A3 '886 Patent, # 4 Exhibit A4 '886 Patent, # 5 Exhibit A5 '886 Patent, # 6 Exhibit B1 '466 Patent, # 7 Exhibit B2 '466 Patent, # 8 Exhibit B3 '466 Patent, # 9 Exhibit C Teva's Q4 Earnings Conference Transcript, # 10 Exhibit D Teva's Q1 2010 Earnings Call, # 11 Exhibit E Teva's Press Release, # 12 Exhibit F Teva's Q2 2010 Earnings Conference Transcript, # 13 Exhibit G Teva Article, # 14 Exhibit H Teva's Q3 2010 Earnings Conference Transcript, # 15 Civil Cover Sheet, # 16 Category Form)(Murawski, Michael) (Entered: 12/02/2010)

Entry #1 • 2010-12-02
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc